Roche lung cancer therapy beats rivals from Amgen, BMS in late-stage trial

Roche lung cancer therapy beats rivals from Amgen, BMS in late-stage trial  Seeking Alpha

Summary aggregated from Seeking Alpha's public RSS feed. The full reporting belongs to Seeking Alpha — please read it on their site.